Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways
- PMID: 29085464
- PMCID: PMC5649540
- DOI: 10.3892/ol.2017.6823
Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways
Abstract
We aimed to investigate the influence of long non-coding RNA (lncRNA) PTEN pseudogene-1 (PTENP1) on the proliferation, migration and cycle of breast cancer cells and its mechanism. Lentiviral vectors expressing PTENP1 were synthesized and breast cancer cells MCF7 were transfected with LV003-GFP-PTENP1 and LV003-GFP, respectively. The proliferation capacities of breast cancer cells were detected using CCK-8 assay, and the migration capacities of breast cancer cells were detected using scratch assay; flow cytometry was used to detect the cell cycles and Western blot was used to detect the expression levels of cyclin A2, CDK2, p-p44/42 MAPK, t-p44/42 MAPK, p-p38 MAPK, t-p38 MAPK, p-AKT, t-AKT in AKT and MAPK pathways. The absorbance values (A450) of cells in experimental group at 48 and 72 h were 1.4±0.3 and 2.3±0.47, respectively, which were significantly lower than those in control group (3.2±0.39, 3.4±0.58) (P<0.05). The number of cell colonies in experimental group was (48±13), which was significantly lower than that in control group (159±16) (P<0.01). The cell migration rate in experimental group was 22.8±3.3%, which was significantly lower than that in control group 61.8±5.2% (P<0.01). Western blot detection showed that the expression levels of cyclin A2, CDK2, p-AKT, p-p44/42 MAPK and p-p38 MAPK in experimental group were significantly decreased compared with those in control group. LncRNA PTENP1 can inhibit the proliferation and migration of breast cancer cells via the AKT and MAPK signaling pathways.
Keywords: PTENP1; breast cancer; cell cycle; lncRNA; migration.
Figures
Similar articles
-
Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro.Onco Targets Ther. 2018 Dec 21;12:147-156. doi: 10.2147/OTT.S182537. eCollection 2019. Onco Targets Ther. 2018. PMID: 30613153 Free PMC article.
-
[Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them].Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):896-901. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23363743 Chinese.
-
Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.Biomaterials. 2015 Mar;44:71-81. doi: 10.1016/j.biomaterials.2014.12.023. Epub 2015 Jan 12. Biomaterials. 2015. PMID: 25617127
-
PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.Cancer Gene Ther. 2017 Jul;24(7):309-315. doi: 10.1038/cgt.2017.29. Epub 2017 Jul 21. Cancer Gene Ther. 2017. PMID: 28731027
-
PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics.Cancers (Basel). 2023 Oct 12;15(20):4954. doi: 10.3390/cancers15204954. Cancers (Basel). 2023. PMID: 37894321 Free PMC article. Review.
Cited by
-
Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.Biol Res. 2023 Jan 3;56(1):1. doi: 10.1186/s40659-022-00411-4. Biol Res. 2023. PMID: 36597150 Free PMC article. Review.
-
Retracted Article: SNHG3 promotes proliferation and invasion by regulating the miR-101/ZEB1 axis in breast cancer.RSC Adv. 2018 Apr 24;8(27):15229-15240. doi: 10.1039/c8ra02090f. eCollection 2018 Apr 18. RSC Adv. 2018. Retraction in: RSC Adv. 2021 Jan 21;11(8):4438. doi: 10.1039/d1ra90025k PMID: 35541333 Free PMC article. Retracted.
-
Retracted Article: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis.RSC Adv. 2019 Nov 19;9(64):37642-37651. doi: 10.1039/c9ra07823a. eCollection 2019 Nov 13. RSC Adv. 2019. Retraction in: RSC Adv. 2021 Feb 3;11(11):6254. doi: 10.1039/d1ra90073k PMID: 35542268 Free PMC article. Retracted.
-
Long Non-Coding RNA and Breast Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819843889. doi: 10.1177/1533033819843889. Technol Cancer Res Treat. 2019. PMID: 30983509 Free PMC article. Review.
-
Knockdown of Long Noncoding RNA POU5F1B Promotes Radiosensitivity in Esophageal Carcinoma.Med Sci Monit. 2019 Feb 14;25:1214-1219. doi: 10.12659/MSM.913066. Med Sci Monit. 2019. PMID: 30763293 Free PMC article.
References
-
- Marzese DM, Gago FE, Vargas-Roig LM, Roqué M. Methylation profile of human breast cancer: A possible biomarker for the detection of circulating tumor cells. J Clin Oncol. 2009;27(Suppl 15):11112.
-
- Perez-Tenorio G, Alkhori L, Olsson B, Waltersson MA, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res. 2007;13:3577–3584. doi: 10.1158/1078-0432.CCR-06-1609. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials